BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aerovance, Inc. 

2929 Seventh Street
Suite 120
Berkeley  California  94710  U.S.A.
Phone: 510-549-5500 Fax: 510-549-5501


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Phase 2b Clinical Trial Results Show Aerovance, Inc.'s Aerovant(TM) is Effective in Patients with Eosinophilic Asthma 6/8/2010 10:15:37 AM
Aerovance, Inc. Secures $38 Million in Equity Financing 4/7/2009 7:27:06 AM
Aerovance, Inc. Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 3/2/2009 10:20:48 AM
Aerovance, Inc. Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer 2/9/2009 10:53:31 AM
Data Show Aerovance, Inc.'s Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 10/7/2008 9:48:59 AM
Aerovance, Inc. Secures $20 Million in Debt Financing 3/28/2008 7:45:17 AM
Aerovance, Inc. Promotes Anthony Rimac to Vice President, Chief Financial Officer 10/30/2007 8:04:17 AM
Aerovance, Inc. Names Mark L. Perry President And CEO 1/4/2007 11:36:46 AM
Aerovance, Inc. Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients 1/3/2007 2:04:26 PM
Aerovance, Inc. Adds Accomplished Product Commercialization Executive To Leadership Team 12/18/2006 11:18:28 AM
12